Siow Ming Lee, Professor of Medical Oncology at University College London, presented the results of the IPSOS trial at the ESMO 2022 Congress.
This was a phase 3 study evaluating first-line atezolizumab vs. single agent chemotherapy in NSCLC patients not eligible for a platinum-based regimen.
Video: https://congressreport.eu/scientific-contents/interview:ipsos-trial
